Ocular Rosacea microBiome Study (ORBS) —sub-microbial versus antibiotic dosing of doxycycline versus placebo in treatment of symptomatic ocular rosacea: study protocol for a parallel-arm randomized clinical trial
DiscussionThese results will enhance our understanding of the overall systemic impact of long-term systemic sub-microbial antibiotic dosing for the treatment of chronic recurrent ocular inflammatory diseases.Trial registrationThis trial was registered on ClinicalTrials.org (NCT05296837) on March 22, 2022.
Source: Trials - Category: Research Source Type: clinical trials
More News: Antimicrobial Resistance | Clinical Trials | Doxycycline | Genetics | Research | Rosacea | Study